Page last updated: 2024-08-23

phorbol 12,13-dibutyrate and Adjuvant Arthritis

phorbol 12,13-dibutyrate has been researched along with Adjuvant Arthritis in 1 studies

Research

Studies (1)

Timeframe	Studies, this research(%)	All Research%
pre-1990	0 (0.00)	18.7374
1990's	1 (100.00)	18.2507
2000's	0 (0.00)	29.6817
2010's	0 (0.00)	24.3611
2020's	0 (0.00)	2.80

Authors

Authors	Studies
Birchall, AM; Bishop, J; Bradshaw, D; Cline, A; Coffey, J; Elliott, LH; Gibson, VM; Greenham, A; Hallam, TJ; Harris, W	1

Other Studies

1 other study(ies) available for phorbol 12,13-dibutyrate and Adjuvant Arthritis

Article	Year
Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation. The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:2 Topics: Administration, Oral; Amino Acid Sequence; Animals; Arthritis, Experimental; Female; Indoles; Lymphocyte Activation; Male; Mice; Molecular Sequence Data; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Rats; Rats, Inbred Lew; T-Lymphocytes	1994

Article

Year

Ro 32-0432, a selective and orally active inhibitor of protein kinase C prevents T-cell activation.

The Journal of pharmacology and experimental therapeutics, 1994, Volume: 268, Issue:2

Topics: Administration, Oral; Amino Acid Sequence; Animals; Arthritis, Experimental; Female; Indoles; Lymphocyte Activation; Male; Mice; Molecular Sequence Data; Phorbol 12,13-Dibutyrate; Protein Kinase C; Pyrroles; Rats; Rats, Inbred Lew; T-Lymphocytes

1994